Guidelines of the Spanish Society of Cardiology. Nuclear cardiology: Technical basis and clinical applications;Guias de actuacion clinica de la Sociedad Espanola de Cardiologia. Cardiologia nuclear: Bases tecnicas y aplicaciones clinicas

Revista Espanola de Cardiologia

Volumn 52, Issue 11, 1999, Pages 957-989

  Candell Riera, Jaume ^b   Castell Conesa, Joan ^b   Jose A ^b   López, Jurado ^b   De Sá, Esteban López ^b   De la Rosa, Nuño ^b   Francisco, J ^b   Ortigosa, Aso ^b   Valle Tudela, Vicente ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE

Author keywords

Isotopes; Nuclear medicine; Perfusion; Scintigraphy; Stress

Indexed keywords

ISOTOPE; TRACER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CARDIOLOGY; DIAGNOSTIC APPROACH ROUTE; ECHOCARDIOGRAPHY; HUMAN; INSTRUMENTATION; NUCLEAR MEDICINE; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SPAIN; TECHNIQUE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; HEART FUNCTION TEST; MANPOWER; METHODOLOGY; QUALITY CONTROL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD;

CARDIOLOGY; HEART FUNCTION TESTS; HUMANS; NUCLEAR MEDICINE; QUALITY CONTROL; RADIOPHARMACEUTICALS; SPAIN; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033498659     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(99)75025-6     Document Type: Review

References (308)

1. Candell Riera J, Ramos Márquez M, Bóveda Romeo FJ, Carreras Delgado JL, Carrie Gasset J, Castro Beiras JM et al. Informe del Grupo de Trabajo de Cardiología Nuclear. Rev Esp Cardiol 1987; 40: 389-396.
2. Gibbons RKJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WFC, Froelicher VF et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on exercise testing). Circulation 1997; 30: 260-315.
3. Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ et al. Guidelines for clinical use of cardiac radionuclide imaging. A report of the American Heart Association/American College of Cardiology Task Force on assessment of diagnostic and therapeutic cardiovascular procedures, Committee on radionuclide imaging, developped in collaboration with the American Society of Nuclear Cardiology. Circulation 1995; 91: 1.278-1.303.
4. Candell Riera J, Bardají Ruiz A, Castell Conesa J, Jurado López JA, Magriñá Ballara J. La cardiología nuclear en la cardiopatía isquémica crónica. Rev Esp Cardiol 1997; 50: 83-91.
5. Freire JM, Rioja ME, Ricart Y, García MJ, Campos L, Jurado JA et al. Situación actual de la cardiología nuclear en España. Resultados de una encuesta realizada en 1994. Rev Esp Med Nuclear 1996; 15: 48-52.
6. Ritchie JL, Gibbons RJ, Johnson LL, Maddahi J, Schelbert HR, Wackers FJT et al. Guidelines for training in adult cardiovascular medicine. Core cardiology training symposium (COCATS). Task Force 5: training in nuclear cardiology. J Nucl Cardiol 1995; 2: 167-171.
7. De los Reyes López M, Iñíguez Romo A, Goicolea de Oro A, Funes López B, Castro Beiras A. El consentimiento informado en cardiología. Rev Esp Cardiol 1998; 51: 782-796.
8. Beller GA, Zaret BL. Wintergreen panel summaries. J Nucl Cardiol 1999; 6: 93-155.
9. Michnich ME, Mills PS, Seidman JJ. The effect of managed care on nuclear cardiology. J Nucl Cardiol 1996; 3: 65-71.
10. Underwood SR, Godman B, Salyani S, Ogle JR, Ell PJ. Economics of myocardial perfusion imaging in Europe-The EMPIRE study. Eur Heart J 1999; 20: 157-166.
11. NEMA standards publication UN 1-1994. Performance measurements of scintillation cameras. Washington: National Electrical Manufacturers Association, 1994.
12. García EV. Equipment and quality control section. Imaging guidelines for nuclear cardiology procedures. J Nucl Cardiol 1996; 3: G5.
13. Richter JA. PET. Tomografía molecular. Fundamentos y aplicaciones. Madrid: Ediciones ESEUVE, S.A., 1993; 17-38.
14. Nichols KJ, Galt JR. Quality control for SPECT imaging. En: Gordon DePuey E, Bennan DS, García EV, editores. Cardiac SPECT imaging. Nueva York: Raven Press, 1995; 21-49.
15. Ortega Alcalde D, Aguadé Bruix S. Radionúclidos, instrumentación y procedimientos. En Candell J, Castell J, Aguadé S, editores. Miocardio en riesgo y miocardio viable. Diagnóstico mediante SPET. Barcelona: Ediciones Doyma S.A., 1998; 6-14.
16. Lebowitz E, Greene MV, Fairchild R, Bradley Moore P, Atkins HL, Ansari AN et al. Thallium-201 for medical use I. J Nucl Med 1975; 16: 151-155.
17. Bradley-Moore PR, Lebowitz E, Greenee MW, Atkins HL, Ansari AN. Thallium-201 for medical use II: Biologic behavior. J Nucl Med 1975; 16: 156-160.
18. Atkins HL, Budinger TF, Lebowitz E, Ansari AN, Greene MW, Fairchild RG et al. Thallium-201 for medical use III: human distribution and physical imaging properties, J Nucl Med 1977; 18: 133-138.
19. L'Abbate A, Biagnini A, Michelassi C, Maseri A. Myocardial kinetics of thallium and potassium in man. Circulation 1979; 60: 776-785.
20. Strauss HW, Harrison K, Langan JK, Lewobitz E, Pitt B. Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circulation 1975; 51: 641-645.
21. Pohost GM, Alpert NM, Ingwall JS, Strauss HW. Thallium redistribution: Mechanisms and clinical utility. Semin Nucl Med 1980; 10: 70-93.
22. 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion. Circulation 1992; 85: 1.531-1.541.
23. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW et al. Technetium-99m hexakis 2 methoxy-isobutyl isonitrile, a new radiopharmaceutical for myocardial perfusion imaging: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging (phase I and II studies). J Nucl Med 1989; 30: 301-311.
24. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med 1991; 21: 173-181.
25. Berman DS, Kiat H, Van Train KF, Friedman J, García EV, Maddahi J. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. Am J Cardiol 1990; 66: 72E-79E.
26. Mousa SA, Cooney JM, Stevens S. Kinetics of technetium-99m-Sestamibi and thallium-201 in a transient ischemic myocardium animal model: insight into the «redistribution» phenomenon. Cardiology 1992; 81: 157-163.
27. Higley B, Smith FW, Smith T, Gemmell HG, Das Grupta P, Gvozdanovic DV et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl)phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-38.
28. Sinusas AJ, Shi Q, Saltzberg MT, Vitols P, Jain D, Wackers FJT, Zaret BL. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994; 35: 664-671.
29. Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin. I: uptake into isolated adult rat ventricular myocites and subcellular localization. J Nucl Cardiol 1995; 2: 317-326.
30. Younès A, Songadele JA, Maublant J, Platts EA, Pickett RD, Veyre A. Mechanism of uptake of technetium-tetrofosmin. II: uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995; 2: 327-333.
31. Ortega-Alcalde D. Myocardial perfusion studies. En: Candell Riera J, Ortega Alcalde D, editores. Nuclear cardiology in everyday practice. Dordrecht: Kluwer Academic Publishers, 1994; 67-87.
32. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
33. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-Fluorodeoxyglucose. Circulation 1991; 83: 26-37.
34. Van Eck-Smit BLF, Van der Wall EE, Kuijper AFM, Zwinderman AH, Pauwels EKJ. Immediate thallium-201 reinjection following imaging: a time-saving approach for detection of myocardial viability. J Nucl Med 1993; 34: 737-743.
35. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Restinjected tallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991; 32: 1.718-1.724.
36. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1.630-1.641.
37. García EV, Cooke CD, Van Train KF, Folks R, Peifer J, DePuey EG et al. Technical aspects of myocardial SPECT imaging, with technetium-99m sestamibi. Am J Cardiol 1990; 66: 23E-31E.
38. Magriñá J, Bosch X, García A, Pons F, Moragas M, Roig E et al. Diagnostic value of technetium-99m-MIBI as a myocardial perfusion imaging agent: comparison of long and short intervals between rest and stress injections. Clin Cardiol 1992; 15: 497-503.
39. Taillefer R. Technetium-99m sestamibi myocardial imaging: same-day rest-stress studies and dipyridamole. Am J Cardiol 1990; 66: 80E-84E.
40. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of Technetium-99m-tetrofosmin: myocardial perfusion imaging agent: Implications for a one-day imaging protocol. J Nucl Med 1993; 43: 1.254-1.259.
41. Sridhara B, Sochor H, Rigo P, Braat S, Itti R, Martinez-Duncker D et al. Myocardial single-photon emission computed tomographic imaging with technetium 99m tetrofosmin: stress-rest imaging with same-day and separate-day rest imaging. J Nucl Cardiol 1994; 1: 138-143.
42. Weinstein H, King MA, Reinhardt CP, McSherry BA, Leppo JA. A method of simultaneus dual-radionuclide cardiac imaging with technetium 99m and thallium 201. Analysis of interradionuclide crossover and validation in phantoms. J Nucl Cardiol 1994; 1: 39-51.
43. Weinmann P, Foult JM, Le Guludec D, Tamgac F, Rechtman D, Neuman A et al. Dual-isotope myocardial imaging: feasibility, advantages and limitations. Eur J Nucl Med 1994; 21: 212-215.
44. Berman DS, Kiat H, Friedman JD, Wang FP, Van Train K, Matzer L et al. Separate acquisition rest thallium-201/stress Tc-99m sestamibi dual isotope myocardial perfusion SPECT: a clinical validation study. J Am Coll Cardiol 1993; 22: 1.455-1.464.
45. Heo J, Wolmer I, Kegel J, Iskandrian AS. Sequential dual-isotope SPECT imaging with thallium-201 and technetium-99m-sestamibi. J Nucl Med 1994; 35: 549-553.
46. Cullom SJ. Principles of Cardiac SPECT. En: DePuey EG, Berman DS, Garcia EV, editores. Cardiac SPECT Imaging. Nueva York: Raven Press Ltd., 1995; 1-19.
47. O'Connor MK, Bothun ED. Effects of tomographic table attenuation on prone and supine cardiac imaging. J Nucl Med 1995; 36: 1.102-1.106.
48. Esquerre JP, Coca FG, Martínez SJ, Guirand RF. Prone decubitus: a solution to inferior wall attenuation in thallium-201 myocardial tomography. J Nucl Med 1989; 30: 398-401.
49. Van Train KF, Garcia EV, Cooke CD, Areeda J. Quantitative analysis of SPECT myocardial perfusion. En: DePuey EG, Berman DS, Garcia EV, editores. Cardiac SPECT Imaging. Nueva York: Raven Press Ltd., 1995; 49-74.
50. Cooke CD, Faber TL, Garcia EV. Advanced computer methods in cardiac SPECT. En: DePuey EG, Berman DS, Garcia EV, editores. Cardiac SPECT Imaging. Nueva York: Raven Press Ltd., 1995; 75-89.
51. Nichols K, DePuey EG, Rozanski A. Automation of gated tomographic left ventricular ejection fraction. J Nucl Cardiol 1996; 3: 475-482.
52. Hambye AS, Dobbeleir A, Derveaux M, Vandevivere J, Van den Heuvel P. Determination of systolic thickening index with gated Tc-99m sestamibi SPECT. A new parameter of myocardial viability? Clin Nucl Med 1997; 22: 172-175.
53. Fukuchi K, Uehara T, Morozumi T, Tsujimura E, Hasegawa S, Yutani K et al. Quantification of systolic count increase in technetium-99m-MIBI gated myocardial SPECT. J Nucl Med 1997; 38: 1.067-1.073.
54. Germano G, Kiat H, Kavanagh PB, Model M, Mazzanti M, Su HT et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2.138-2.147.
55. Germano G, Erel J, Kiat H, Kavanagh PB, Berman DS. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT. J Nucl Med 1997; 38: 749-754.
56. Galt JR, Germano G. Advances in instrumentation for Cardiac SPECT. En: DePuey EG, Berman DS, Garcia EV, editores. Cardiac SPECT Imaging. Nueva York: Raven Press Ltd., 1995; 91-102.
57. He ZX, Scarlett MD, Mahmarian JJ, Verani MS. Enhanced accuracy of defect detection by myocardial single-photon emission computed tomography with attenuation correction with gadolinium 153 line sources: evaluation with a cardiac phantom. J Nucl Cardiol 1997; 4: 202-210.
58. Ficaro EP, Fessler JA, Rogers L, Schwaiger M. Comparison of americium-241 and technetium-99m as transmission sources for attenuation correction of thallium-201 SPECT imaging of the heart. J Nucl Med 1994; 35: 652-663.
59. Ficaro EP, Fessler JA, Ackermann RJ, Rogers WL, Corbett JR, Schwaiger M. Simultaneous transmission-emission thallium-201 cardiac SPECT: effect of attenuation correction on myocardial tracer distribution. J Nucl Med 1995; 36: 921-931.
60. Gill JB, Ruddy TD, Newell JB, Finkelstein DM, Strauss HW, Boucher CA. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987; 317: 1.485-1.489.
61. Puchal R. Filtros de imagen en medicina nuclear. Madrid: Ed. Eurobook S.L., 1997.
62. Gilland DR, Tsui BMW, McCartney WH, Perry JR, Berg J. Determination of the optimum filter function for SPECT imaging. J Nucl Med 1988; 29: 643-650.
63. Committee on Advanced Cardiac Imaging and Technology, Council on Clinical Cardiology, American Heart Association; Cardiovascular Imaging Committee, American College of Cardiology; and Board of Directors, Cardiovascular Council, Society of Nuclear Medicine, Standarization of Cardiac Tomographic Imaging. Circulation 1992; 86: 338-399.
64. Rosenthal MS, Cullom J, Hawkins W, Moore SC, Tsui BM, Yester M. Quantitative SPECT imaging: a review and recommendations by the Focus Committee of the Society of Nuclear Medicine Computer and Instrumentation Council. J Nucl Med 1995; 36: 1.489-1.513.
65. Aguadé S, Castell J. Métodos de cuantificación. En: Candell J, Castell J, Aguadé S, editores. Miocardio en riesgo y miocardio viable. Diagnóstico mediante SPET. Barcelona: Doyma, 1998; 51-75.
66. Srivastava SC, Straub RF. Blood cell labeling with 99mTc: progress and perspectives. Semin Nucl Med 1990; 20: 41-51.
67. Subramanian KM. Cardiac blood-pool tracers. J Nucl Med 1991; 32: 480-483.
68. Iskandrian AS, Verani MS. Radionuclide angiography. En: Iskandrian AS, Verami MS, editores. Nuclear cardiac imaging: principles and applications. Filadelfia: FA Davis Company, 1995; 144-218.
69. Wackers F̀J, Berger HJ, Johnstone DE, Goldman L, Reduto LA, Langou G et al. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assesment of variability. Am J Cardiol 1979; 43: 1.159-1.166.
70. Candell Riera J, Ortega Alcalde D, Castell Conesa J. Ventriculografía isotópica. I. Fracción de eyección ventricular global y segmentaria. Med Clin (Bare) 1985; 85: 154-160.
71. Upton MT, Rerych SK, Newman GE, Bounous EP, Jones RH. The reproductibility of radionuclide angiographic measurement of left ventricular function in normal subjects at rest and during exercise. Circulation 1980; 62: 126-132.
72. Christian PE, Nortmann CA, Taylor A. Comparison of fully automated and manual ejection fraction calculations: validation and pitfalls. J Nucl Med 1985; 26: 775-782.
73. Bashore TM, Leithe ME, Shaffer P. Diastolic function. En: Gerson MC, editor. Cardiac nuclear medicine. Nueva York: McGraw-Hill, 1991; 195-218.
74. Bonow RO. Radionuclide evaluation of left ventricular diastolic function. Circulation 1991; 84 (Supl 1): 208-215.
75. Links JM, Becker LC, Shindledecker JG, Guzman P, Burow RD, Nickoloff EL et al. Measurement of absolute left ventricular volume from gated blood pool studies. Circulation 1982; 65: 82-90.
76. Maurer AH, Siegel JA, Denenberg BS, Carabello BA, Gash AK, Spann JF et al. Absolute left ventricular volume from gated blood pool imaging with use of esophageal transmission measurement. Am J Cardiol 1983; 51: 853-858.
77. Massardo T, Gal RA, Grenier RP, Schmidt DH, Port SC. Left ventricular volume calculation using a count-based ratio method applied to multigated radionuclide angiography. J Nucl Med 1990; 31: 450-456.
78. Jeremy R, Tokuyasu Y, Choong CYP, Bautovich G, Hutton BF, Shen WF et al. The reproductibility of nongeometric analysis of cardiac output and left ventricular volume by radionuclide angiography. Am Heart J 1985; 110: 1.020-1.026.
79. Botvinick EH, Frais MA, Shosa DW, O'Connell JW, Pacheco-Alvarez JA, Scheinman M et al. An accurate means of detecting and characterizing abnormal patterns of ventricular activation by phase image analysis. Am J Cardiol 1982; 50: 289-298.
80. Gibbons RJ, Morris KG, Lee K, Coleman RE, Cobb FR. Assessment of regional left ventricular function using gated radionuclide angiography. Am J Cardiol 1984; 54: 294-300.
81. Ortega Alcalde D, Candell Riera J, Pavia Segura X. Ventriculografía isotópica. II. Imágenes paramétricas o funcionales. Análisis de Fourier. Med Clin (Bare) 1985; 85: 373-379.
82. Sporn V, Pérez-Balino N, Holman BL. Simultaneous measurement of ventricular function and myocardial perfusion using the technetium-99m isonitriles. Clin Nucl Med 1988; 13: 77-81.
83. Iskandrian AS, Heo J, Kong B, Lyons E, Marsch S. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am J Cardiol 1989; 64: 270-275.
84. Takahashi N, Tamaki N, Tadamura E, Kawamoto M, Torizuka T, Yonekura Y et al. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium 99m tetrofosmin. J Nucl Cardiol 1994; 1: 29-38.
85. Harpen MD, Dubuisson RL, Head GB, Parmley LF, Jones TB, Robinson AE. Determination of left-ventricular volume from first-pass kinetics of labeled red cells. J Nucl Med 1983; 24: 98-103.
86. Nusymowitz ML, Benedetto AR, Walsh RA, Starling MR. First-pass Anger camera radiography: biventricular ejection fraction, flow and volume measurements. J Nucl Med 1987; 28: 950-959.
87. Kelbaek H, Hartling OJ, Skagen K, Munck O, Henriksen O, Godtfredsen J. First-pass radionuclide determination of cardiac output: an improved gammacamera method. J Nucl Med 1987; 28: 1.330-1.334.
88. Benedetto AR, Nusymowitz ML. Correlation of right and left ventricular ejection fraction and volume measurements. J Nucl Med 1988; 29: 1.114-1.117.
89. Maltz DL, Treves S. Quantitative radionuclide angiocardiography. Determination of QP: QS in children. Circulation 1973; 47: 1.049-1.056.
90. Baker EJ, Ellam SV, Lorber A, Jones ODH, Tynam MJ, Maisey MN. Superiority of radionuclide over oximetric measurement of left to right shunts. Br Heart J 1985; 53: 535-540.
91. Henderson EB, Khan JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P. Abnormal I-123-metaiodobenzylguanidine washout and distribution may reflect myocardial adrenergic derangment in patients with congestive cardiomyopathy. Circulation 1988; 78: 1.192-1.198.
92. Beau SL, Saffitz JE. Transmural heterogeneity of norepinephrine uptake in failing human hearts. J Am Coll Cardiol 1994; 23: 579-585.
93. Böhm M, La Rosee K, Schwinger RH, Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 1995; 25: 146-153.
94. Bonte FJ, Parkey RW, Graham KD, Mohr J, Stokely EM. A new method for radionuclide imaging of myocardial infarcts. Radiology 1974; 110: 473-474.
95. Buja LM, Tofe AJ, Kulkarni PV, Mukherjee A, Parkey RW, Francis MD et al. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues. J Clin Invest 1977; 60: 724-740.
96. Holman BL, Golhaber SZ, Kirsch CM, Polak JF. Friedman BJ, English RJ et al. Measurement of infarct size using single photon emission computed tomography and 99mTc-pyrophasphate: a description of the method and a comparison with patient prognosis. Am J Cardiol 1982; 50: 503-511.
97. Cortadellas Ángel J, Candell Riera J, Castell Conesa J, Fraile López-Amor M, González González JM, Soler Soler J et al. Detección del infarto agudo de miocardio sin onda Q; anticuerpos antimiosina marcados con indio-111 frente a radiofosfatos marcados con tecnecio-99m. Rev Esp Cardiol 1993; 46: 152-159.
98. Khaw BA, Yasuda T, Gold HK. Acute myocardial infarct imaging with 111-Indium labeled monoclonal antimyosin Fab. J Nucl Med 1987; 28: 1.671-1.678.
99. Ballester Rodés M, Carrió Gasset I, Abadal Berini LL, Obrador Mayol D, Berná Roqueta LL, Caralps Riera JM. Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111 monoclonal antimyosin. Am J Cardiol 1988; 62: 623-627.
100. Yasuda T, Palacios IF, Dec GW, Fallon JT, Gold HK, Leinbach RC et al. Indium-111 monoclonal antimyosin antibody imaging in the diagnosis of myocarditis. Circulation 1987; 76: 306-311.
101. Estorch M, Canió I, Berná LL, Martínez-Dunker C, Alonso C, Germa JR et al. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med 1990; 31: 1.965-1.969.
102. Schwaiger M. Myocardial perfusion imaging with PET. J Nucl Med 1994; 35: 693-698.
103. Schelbert HR, Phelps ME, Huang SC, MacDonald NS, Hansen H, Selin C, Kuhl DE et al. Nitrogen-13 ammonia as an indicator of myocardial blood flow. Circulation 1981; 63: 1.259-1.272.
104. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990; 15: 1.032-1.042.
105. Mullani NA, Goldstein RA, Gould KL, Marani SK, Fisher DJ, O'Brien HA Jr et al. Perfusion imaging with rubidium-82: I. Measurement of extraction and flow with external detectors. J Nucl Med 1983; 24: 898-906.
106. Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O'Brien HA Jr. Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med 1983; 24: 907-915.
107. Bergmann SR, Fox KAA, Rand AL, McElvany KD, Welch MJ, Markham J et al. Quantification of regional myocardial blood flow in vivo with H215O. Circulation 1984; 70: 724-733.
108. Iida H, Kanno I, Takahashi A, Miura S, Murakami M, Takahashi K et al. Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988; 78: 104-115.
109. Schelbert HR, Czernin J, Huang SC. Quantitation of regional myocardial blood flow: oxygen-15-water versus nitrogen-13-ammonia. J Nucl Med 1990; 31: 1.431-1.433.
110. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 1989; 14: 639-652.
111. Phelps ME, Hoffman EJ, Selin CE, Huang SC, Robinson G, MacDonald N et al. Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med 1978; 19: 1.311-1.319.
112. Ratib O, Phelps ME, Huang SC, Henzse E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982; 23: 577-586.
113. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography 18-F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983; 67: 766-778.
114. Schwaiger M, Hicks R, The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565-578.
115. Gropler RJ, Geltman EM, Sampathkumaran K, Perez JE, Schechtman KB, Conversano A et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomographay. J Am Coll Cardiol 1993; 22: 1.587-1.597.
116. Walsh MN, Geltman EM, Brown MA, Henes CG, Weinheimer CJ, Sobel BE et al. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med 1989; 30: 1.798-1.808.
117. Coleman RE, Klein MS, Roberts R, Sobel BE. Improved detection of myocardial infarction with technetium-99mMB creatine phosphokinase. Am J Cardiol 1976; 37: 732-725.
118. Corbett JR, Lewis M, Willerson JT, Nicod PH, Huxley RL, Simon T et al. 99m-Tc-pyrophosphate imaging in patients with acute myocardial infarction: comparison of planar imaging with single-photon tomography with and without blood pool overlay. Circulation 1984; 69: 1.120-1.128.
119. Croft CH, Rude RE, Lewis SE, Parkey RW, Poole WK, Parker C et al. Comparison of left ventricular function and infarct size in patients with and without persistently positive technetium 99m pyrophosphate myocardial scintigrams after myocardial infarction. Am J Cardiol 1984; 53: 421-428.
120. Massie BM, Botvinick EH, Werner JA, Chatterjee K, Parmley WW. Myocardial scintigraphy with technetium-99 m stannous pyrophosphate: an insensitive test for nontransmural myocardial infarction. Am J Cardiol 1979; 43: 186-192.
121. Candell Riera J, Valle Tudela V. Gammagrafía cardíaca con pirofosfato de tecnecio. Imagen positiva del infarto agudo de miocardio. Rev Esp Cardiol 1981; 34: 105-114.
122. Reduto LA, Berger HJ, Cohen LS, Gottschalk A, Zaret BL. Sequential radionuclide assessment of left an right ventricular performance after acute transmural myocardial infarction. Ann Intern Med 1978; 89: 441-447.
123. Candell Riera J, Figueras J, Valle V. Álvarez A, Gutiérrez L, Cortadellas J et al. Right ventricular infarction: relationships between ST segment elevation in V4R and hemodynamic, scintigraphic and echocardiographic findings in patients with acute inferior myocardial infarction. Am Heart J 1981; 101: 281-287.
124. Candell Riera J, Valle Tudela V, Cortadellas J, Álvarez A, Rius J. Angor prolongado versus infarto agudo de miocardio no transmural. Utilidad clínica de la gammagrafía cardíaca con pirofosfato de tecnecio. Rev Esp Cardiol 1981; 34: 49-54.
125. Johnson LL, Seldin DW, Becker LC, LaFrance ND, Liberman HA, James C et al. Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial. J Am Coll Cardiol 1989; 13: 27-35.
126. Shah P, Pichler M, Berman D, Singh BN, Swan HJ. Left ventricular ejection fraction determined by radionuclide ventriculogrphy in early states of first transmural myocardial infarction: relation to short term prognosis. Am J Cardiol 1980; 45: 542-549.
127. Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield JC Jr, Becker LC et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study: comparison of unconscious and conscious dog models. Circ Res 1985; 56: 651-665.
128. Feiring AJ, Johnson MR, Kioschos JM, Kirchner PT, Marcus ML, White CW. The importance of the determinants of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction patients. Circulation 1987; 75: 980-987.
129. The Multicenter Post-Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-336.
130. Cerqueira MD, Maynard C, Ritchie JL, Davis KB, Kennedy JW. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials. J Am Coll Cardiol 1992; 20: 1.452-1.459.
131. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. Circulation 1993; 88: 416-429.
132. Behrenbeck T, Pellikka PA, Huber KC, Bresnahan JF, Gersh BJ, Gibbons RJ. Primary angioplasty in myocardial infarction: assessment of improved myocardial perfusion with technetium-99m isonitrile. J Am Coll Cardiol 1991; 17: 365-372.
133. Candell Riera J, Permanyer Miralda G, Castell J, Rius Daví A, Domingo E, Álvarez Auñón E et al. Uncomplicated first myocardial infarction: strategy for comprehensive prognostic studies. J Am Coll Cardiol 1991; 18: 1.207-1.219.
134. Olona M, Candell Riera J, Permanyer Miralda G, Castell J, Barrabés JA, Domingo E et al. Strategies for prognostic assessment of uncomplicated first myocardial infarction: 5-year follow-up study. J Am Coll Cardiol 1995; 25: 815-822.
135. St. Gibson W, Christian T, Pellikka P, Behrenbeck T, Gibbons RJ. Serial tomographic imaging with technetium-99msestamibi for the assessment of infarct related arterial patency following reperfusion therapy. J Nucl Med 1992; 33: 2.080-2.085.
136. O'Rourke M, Barón D, Keogh A, Kelly R, Nelson G, Barnes C et al. Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator. Circulation 1988; 77: 1.311-1.318.
137. Maseri A, Parodi O, Severi S, Pesola A. Transient transmural reduction of myocardial blood flow, demonstrated by thallium-201 scintigraphy, a cause of variant angina. Circulation 1976; 54: 280-288.
138. Wackers FJ, Lie KI, Liem KL, Sokole EB, Samson G, Der School et al. Thallium-201 scintigraphy in unstable angina pectoris. Circulation 1978; 57: 738-742.
139. Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin DM et al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 1994; 90: 613-622.
140. Califf RM, Harrell FE, Lee KL, Rankin JS, Hlatky MA, Mark DB et al. The evolution of medical and surgical therapy for coronary artery disease: a 15-year perspective. JAMA 1989; 261: 2.077-2.086.
141. Gould KL. Noinvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation, I: physiologic basis and experimental validation. Am J Cardiol 1978; 41: 267-278.
142. Gould KL, Wescott RJ, Albro PC, Hamilton GW. Noninvasive assesment of coronary stenosis by myocardial imaging during pharmacologic vasodilatation. II: Clinical methodology and feasibility. Am J Cardiol 1978; 41: 279-287.
143. Albro PC, Gould KL, Westcott RJ, Hamilton GW, Ritchie JL, Williams DL. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation, II: Clinical trial. Am J Cardiol 1978; 42: 751-760.
144. Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilatation with adenosine for assessing coronary artery disease. J Am Coll Cardiol 1991; 18: 736-745.
145. Leppo JA. Dypiridamole -thallium imaging: the lazy man's stress test. J Nucl Med 1989; 30: 281-287.
146. Verani MS, Mahmariam J, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilatation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990; 82: 80-87.
147. Nguyen T, Heo J, Ogilby JD, Iskandrian AS. Single-photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography. J Am Coll Cardiol 1990; 16: 1.375-1.383.
148. Coyne EP, Belvedere DA, Vande Streek PR, Weiland FL, Evans RB, Spaccavento LJ. Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease. J Am Coll Cardiol 1991; 17: 1.289-1.294.
149. Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 single photon emission computed tomography (SPECT) myocardial perfusion imaging. J Am Coll Cardiol 1992; 19: 248-257.
150. Ogilby JD, Iskandrian AS, Untereker WJ, Heo J, Nguyen TN, Mercuro J. Effect of intravenous adenosine infusion on myocardial perfusion and function: hemodynamic/angiographic and scintigraphic study. Circulation 1992; 86: 887-895.
151. Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial. J Am Coll Cardiol 992; 20: 265-275.
152. Abreu A, Mahmarian JJ, Nishimura S, Boyce TM, Verani MS. Tolerance and safety of pharmacologic coronary vasodilatation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 1991; 18: 730-735.
153. Mason JR, Palac RT, Freeman ML, Virupannavar S, Loeb HS, Kaplan E et al. Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease. Am Heart J 1984; 107: 481-485.
154. Pennell DJ, Underwood SR, Swanton RH, Walker JM, Ell PJ. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991; 18: 1.471-1.479.
155. Marwic T, Willemart B, D'Hondt AM, Baudhuin T, Wijns W, Detry JM et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion: comparison of dobutamine and adenosine using echocardiography and Tc-99m MIBI single photon emission computed tomography. Circulation 1982; 87: 345-354.
156. Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patiens with suspected coronary artery disease unable to undergo exercise or vasodilatador pharmacologic stres testing. J Am Coll Cardiol 1993; 21: 1.583-1.590.
157. Verani MS. Pharmacologic stress myocardial perfusion imaging. Curr Probl Cardiol 1993; 18: 481-525.
158. 99mTc MIBI SPECT. Improved diagnostic yield in coronary artery disease. J Am Coll Cardiol 1997; 29: 531-536.
159. Esquivel L, Pollock SG, Beller GA, Gibson RS, Watson DD, Kaul S. Effect of the degree of effort on the sensitivity of the exercise thallium-201 stress test in symptomatic coronary artery disease. Am J Cardiol 1989; 63: 160-165.
160. Braat SH, Brugada P, Bar FW, Gorgels APM, Wellens HJJ. Thallium-201 exercise scintigraphy and left bundle branch block. Am J Cardiol 1985; 55: 224-226.
161. Hirzel HO, Senn M, Nuesch K, Buettner C, Pfeiffer A, Hess OM et al. Thallium-201 scintigraphy in complete left bundle branch block. Am J Cardiol 1984; 53: 764-769.
162. DePuey EG, Guertler-Krawcznska E, Robbins WL. Thallium-201 SPECT in coronary artery disease patients with left bundle branch block. J Nucl Med 1988; 29: 147-148.
163. Burns RJ, Galligan L, Wright LM, Lawand S, Burke RJ, Gladstone PJ. Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block by dipyridamole. Am J Cardiol 1991; 68: 504-508.
164. Rockett JF, Wood WC, Moinuddin M, Loveless V, Parrish B. Intravenous dipyridamole thallium-201 SPECT imaging in patients with left bundle branch block. Clin Nucl Med 1990; 15: 401-407.
165. O'Keefe JH Jr, Baterman TM, Silvestri R, Barnhart C. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block. Am Heart J 1992; 124: 614-621.
166. Bonow RO, Kent KM, Rosing DR, Lan KK, Lakatos E, Borer JS et al. Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. N Engl J Med 1984; 311: 1.339-1.345.
167. Lee KL, Pryor DB, Pieper KS, Harrell FE Jr, Califf RM, Mark DB et al. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease: a comparison with clinical and catheterization variables. Circulation 1990; 82: 1.705-1.717.
168. Wong T, Detsky AS. Preoperative cardiac risk assessment for patients having peripheral vascular surgery. Ann Intern Med 1992; 116: 743-753.
169. Ashton CM, Petersen NJ, Wray NP, Kiete CI, Dunn JK, Wu L et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993; 118: 504-510.
170. DePuey EG, Rozanski A. Gated Tc-99m sestamibi SPECT to characterize fixed defects as infarct or artifact. J Nucl Med 1995; 36; 952-955.
171. Mannting F, Morgan-Mannting M. Gated SPECT with technetium-99m sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med 1995; 34: 601-608.
172. Sugihara H, Tamaki N, Nozawa M, Ohmura T, Inamoto Y, Taniguchi Y et al. Septal perfusion and wall thickening in patients with left bundle branch block assessed by technetium-99m-sestamibi gated tomography. J Nucl Med 1997; 38: 545-547.
173. Schelbert HR, Wisenberg G, Phelps ME, Gould KL, Henze E, Hoffman EJ et al. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation, VI: detection of coronary artery disease in human beings with intravenous N-13 ammonia and computed tomography. Am J Cardiol 1982; 49: 1.197-1.207.
174. Gould KL, Goldstein RA, Mullani NA, Kirkeeide RL, Wong WH, Tewson TJ et al. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation, VIII: clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. Am J Cardiol 1986; 7: 775-789.
175. Goldstein RA, Kirkeeide RL, Smalling RW, Nishikawa A, Merhige ME, Demer LL et al. Changes in myocardial perfusion reserve after PTCA: noninvasive assessment with positron tomography. J Nucl Med 1987; 28: 1.262-1.267.
176. Tamaki N, Yonekura Y, Senda M, Yamashita K, Koide H, Saji H et al. Value and limitation of stress thallium-201 single photon emission computed tomography: comparison with nitrogen-13 ammonia positron tomography. J Nucl Med 1988; 29: 1.181-1.188.
177. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL. Noninvasive assessment of coronary collaterals in man by PET perfusion imaging. J Nucl Med 1990; 31: 259-270.
178. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW et al. Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative arteriography in 193 patiens. Circulation 1989; 79: 825-835.
179. Go RT, Marwick TH, MacIntyre WJ, Saha GB, Neumann DR, Underwood DA et al. A prospective comparison of rubidium-82 positron PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990; 31: 1.899-1.905.
180. Stewart RE, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus M et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991; 67: 1.303-1.310.
181. Grover-McKay M, Rtib O, Schwaiger M, Wohlgelernter D, Araujo L, Nienabetr C et al. Detection of coronary artery disease with positron emission tomography and rubidium-82. Am Heart J 1992; 123: 646-652.
182. Bonow RO, Berman DS, Gibbons RJ, Johnson LL, Rumberger J, Schwaiger M et al. Cardiac positron emission tomography: a report for health professionals from the Committee on Advanced Cardiac Imaging and Technology of the Council on Clinical Cardiology, American Heart Association. Circulation 1991; 84: 447-454.
183. Fintel DJ, Links JN, Brinker JA, Frank TL, Parker M. Becker LC. Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis. J Am Coll Cardiol 1989; 13: 600-612.
184. Kiat H, Berman DS, Maddahi J. Comparison of planar and tomography exercise thallium-201 imaging methods for the evaluation of coronary artery disease. J Am Coll Cardiol 1989; 13: 613-616.
185. Kiat H, Maddahi J, Roy LT, Train KV, Friedman J, Resser K et al. Comparison of technetium-99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomography methods. Am Heart J 1989; 117: 1-11.
186. Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983; 1: 994-1001.
187. Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary disease. J Am Coll Cardiol 1986; 7: 464-471.
188. Hendel RC, Layden JJ, Leppo JA. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990; 15: 109-116.
189. Iskandrian AS, Heo J, Decoskey D, Askenase A, Segal BL. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary disease. Am J Cardiol 1988; 61: 269-272.
190. Kaul S, Lilly DR, Gasho JA, Watson DD, Gibson RS, Oliner CA et al. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization. Circulation 1988; 77: 745-758.
191. Staniloff HM, Forrester JS, Berman DS, Swan HJC. Prediction of death, myocardial infarction and worsening chest pain using thallium scintigraphy and exercise electrocardiography. J Nucl Med 1986; 27: 1.842-1.848.
192. Stratman HG, Mark AL, Walter KE, Williams GA. Prognostic value of atrial pacing and thallium-201 scintigraphy in patients with stable chest pain. Am J Cardiol 1989; 64: 985-990.
193. Younis LT, Byrs S, Shaw L, Barth G, Goodgold H, Chaitman BR. Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole thallium myocardial imaging in asymptomatic patients with coronary artery disease. J Am Coll Cardiol 1989; 14: 1.635-1.641.
194. Kaul S, Finkelstein DM, Homma S, Leavitt M, Okada RD, Boucher CA. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol 1988; 12: 25-34.
195. Iskandrian AS, Lichtenberg R, Segal BL, Mintz GS, Mundth DE, Hakki AH et al. Assessment of jeopardized myocardium in patients with one-vessel disease. Circulation 1982; 65: 242-247.
196. Hadjimiltiades S, Watson R, Hakki AH, Heo J, Iskandrian AS. Relation between myocardial thallium-201 kinetics during exercise and quantitative coronary angiography in patients with one vessel coronary disease. J Am Coll Cardiol 1989; 3: 1.301-1.308.
197. Mahmariam JJ, Pratt CM, Boyce TM, Verani MS. The variable extent of jeopardized myocardium in patients with single vessel coronary artery disease: quantification by thallium-201 single photon emission computed tomography. J Am Coll Cardiol 1991; 17: 355-362.
198. Matzer L, Kiat H, Van Train K, Germano G, Papanicolaou M, Silagan G et al. Quantitative severity of stress thallium-201 myocardial perfusion single-photon emission computed tomography defects in one - vessel coronary artery disease. J Am Coll Cardiol 1993; 72: 273-279.
199. Boucher CA, Zir LM, Beller GA, Okada RD, McKusick KA, Strauss HW et al. Increased lung uptake of thallium-201 during exercise myocardial imaging: clinical, hemodynamic and angiographyc implications in patients with coronary artery disease. Am J Cardiol 1980; 46: 189-196.
200. Nishimura S, Mahmarian JJ, Verani MS. Significance of increased lung tallium uptake during adenosine thallium-201 scintigraphy. J Nucl Med 1992; 33: 1.600-1.607.
201. Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ et al. Transient ischemic dilation of ventricle on stress thalium-201 scintigraphy: a marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987; 9: 752-759.
202. Maddahi J, Abdulla A, Garcia EV, Swan HJC, Berman DS. Non invasive identification of left main and triple vessel coronary artery disease: improved accuracy using quantitative analysis of region myocardial stress distribution and wash-out of thallium-201. J Am Coll Cardiol 1986; 7: 53-60.
203. Rehn T, Griffith LS, Achuff SC, Bailey IK, Bulkley BH, Burow R et al. Exercise thallium-201 myocardial imaging in left main coronary artery disease: sensitive but not specific. Am J Cardiol 1981; 48: 217-223.
204. Nygaard TW, Gibson RS, Ryan JN, Gascho JA, Watson DD, Beller GA. Prevalence of high-risk thallium-201 scintigraphic findings in left main coronary artery stenosis: comparison with patients with multiple-and single -vessel coronary artery disease. Am J Cardiol 1984; 53: 462-469.
205. Christian TF, Miller TD, Mailey KR, Gibbons RJ. Noninvasive identification of severe coronary artery using exercise tomography thallium-201 imaging. J Am Coll Cardiol 1992; 70: 14-20.
206. Iskandrian AS, Heo J, Lemlek J, Ogilby JD. Identification of high-risk patients with left main and three-vessel coronary artery disease using stepwise discriminant analysis of clinical, exercise and tomographic thallium data. Am Heart J 1993; 125: 221-225.
207. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993; 22: 665-670.
208. Iskandrian AS, Hakki AH, Kane-Marsch S. Exercise thallium-201 scintigraphy in men with nondiagnostic exercise electrocardiograms: pronostic implications. Arch Intern Med 1986; 146: 2.189-2.193.
209. Fleg JL, Girstenblith G, Zonderman AB, Becker LC, Weisfeldt MN, Costa PT et al. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 1990; 81: 428-436.
210. Wahl JM, Hakki AH, Iskandrian AS. Prognostic implications of normal exercise thallium-201 images. Arch Intern Med 1985; 145: 253-256.
211. Pamelia FX, Gibson RS, Watson DD, Craddock GB, Sirowatka J, Beller GA. Prognosis with chest pain and normal thallium-201 exrcise scintigrams. Am J Cardiol. 1985; 55: 920-926.
212. Wackers FJ, Russo D, Clements JP. Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. J Am Coll Cardiol 1985; 6: 27-30.
213. Heo J, Thompson WO, Iskandrian AS. Prognostic implication of normal exercise thallium images. Am J Noninvasive Cardiol 1987; 1: 209-212.
214. Bairey CN, Rozanski A, Maddahi J, Resser KJ, Berman DS. Exercise thallium-201 scintigraphy and prognosis in typical angina pectoris and negative exercise electrocardiography. Am J Cardiol 1989; 64: 282-287.
215. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. Circulation 1991; 83: 363-381.
216. National Center for Healt statistics. Vital statistisc of the Unite States, 1979, Vol II: Mortality, Part A, Washington DC: US Governmement Printing Office: 1984. US Dept of Health and Human Services, Publication (PHS) 84-1101.
217. Harris PJ, Harrell FE Jr, Lee KL, Behar VS, Rosati RA. Survival in medically treated patients in the coronary artery disease. Circulation 1979; 60: 1.259-1.269.
218. Mock MB, Ringqvist I, Fisher LD, Davis KB, Kouchoukos NT, Kaiser GC et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982; 66: 562-568.
219. Jones RH, Floyd RD, Austin EH, Sabiston DC Jr. The role of radionuclide angiocardiography in the preoperative prediction of pain relief and prolonged survival following coronary artery bypass grafting. Ann Surg 1983; 197: 743-754.
220. Pryor DB, Harrell FE Jr, Lee KL, Rosati RA, Coleman RE, Cobb FR et al. Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol 1984; 53: 18-22.
221. Mazzotha G, Bonow RO, Pace L, Brittain E, Epstein SE. Relation between exertional ischemia and prognosis in mildly symptomatic patients with single or double vessel coronary artery disease and left ventricular dysfunction at rest. J Am Coll Cardiol 1989; 13: 567-573.
222. Miller TD, Taliercio CP, Zinmeister AR, Gibbons RJ. Risk stratification of single or double vessel coronary artery disease and impaired left ventricular function using exercise radionuclide angiography. Am J Cardiol 1990; 65: 1.317-1.321.
223. Candell-Riera J, Castell J, Aguadé S, Olona M, Rosselló J, Permanyer G. Cardiología no invasiva después de un primer infarto no complicado. Análisis multivariable. Rev Esp Cardiol 1990; 43: 34.
224. Maddahi J, Kiat H, Van Train KF, Prigent F, Friedman J, Garcia EV et al. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990; 66: 55E-62E.
225. Borges-Neto S, Coleman RE, Potts JM, Jones RH. Combined exercise radionuclide angiocardiography and single photon emission computed tomography perfusion studies for assessment of coronary artery disease. Semi Nucl Med 1991; 21: 223-229.
226. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium. Circulation 1993; 87: 1-20.
227. Gibson RS, Watson DD, Taylor GJ, Crosby IK, Wellons HL, Holt ND et al. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1983; 1: 804-815.
228. Kiat H, Berman DS, Maddahi J, Yang FL, Train KV, Rozanski et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 1988; 12: 1.456-1.463.
229. Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990; 66: 394-399.
230. Vanoverschekle JLJ, D'Hont AM, Marwick T, Gerber B, Kock M, Dion R et al. Head-to-head comparison of execise-redistribution-reinjection thallium single photon emission tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996; 28: 432-442.
231. Arnese M, Cornel JH, Salustri A, Maat AP, Elhendy A, Reijs AEM et al. Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low dose dobutamine echocardiography with 201-TI SPECT. Circulation 1995; 91: 2.748-2.752.
232. Tamaki N, Ohtani H, Yonekura Y, Nohara R, Kambara H, Kawai C et al. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional motion and angiographic findings. J Nuc Med 1990; 31: 1.617-1.623.
233. Haque T, Furukawa T, Takashashi M, Kinoshita M. Identification of hibernating myocardium by dobutamine stress echocardiography: comparison with thallium-201 reinjection imaging. Am Heart J 1995; 130: 553-563.
234. Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NMT et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Circulation 1993; 88: 941-952.
235. Galassi AR, Centamore G, Fiscella A, Coppola A, Liberi F, Franco M et al. Comparison of rest-redistribution thallium imaging and reinjection after stress-redistribution for the assessement of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease. Am J Cardiol 1995; 75: 436-442.
236. Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991; 32: 673-678.
237. Altehoefer C, Von Dahl J, Buell U, Uebis R, Kleinhans E, Hanrath P. Comparison of thallium-201 single photon emission tomography after rest injection and fluorodeoxyglucosa positron emision tomography for assessment of myocardial viability in patients with chronic coronary artery disease. Eur J Nucl Med 1994; 21: 37-45.
238. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled date. J Am Coll Cardiol 1997; 30: 1.451-1.460.
239. Castell J, Candell J, Rosselló J, López-Amor FJ, Sos FH, Aguadé S et al. Valoración de la viabilidad miocárdica mediante tecnecio-99m isonitrilio y talio-201. Resultados del protocolo multicéntrico español. Rev Esp Cardiol 1997; 50: 320-330.
240. Castell Conesa J, González González JM. Diagnóstico isotópico del miocardio viable. En: Candell J, Castell J, Aguadé S, editores. Barcelona: Ediciones Doyma S.A., 1998; 203-236.
241. Nakajima K, Taki J, Shuke N, Bunko H, Takala S, Hisda K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34: 1.478-1.484.
242. Matsunari I, Fijino S, Taki J, Senma J, Aoyama T, Wakasugui T et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995; 36: 1.961-1.967.
243. He ZX, Dacourt J, Guignier A, Ferrari E, Bussière F, Baudouy M et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med 1993; 34: 1.472-1.477.
244. He ZX, Medrano R, Hays JT, Mahmarian JJ, Verani MS. Nitroglycerin-augmented TI-201 reinjeclion enhances detection of reversible myocardial hypoperfusion. A randomized, doubleblind, parallel, placebo-controlled trial. Circulation 1997; 95: 1.799-1.805.
245. Basu S, Senior R, Raval U, Lahiri A. Superiority of nitrate-enhanced TI-201 over conventional redistribution TI-201 imaging for prognostic evaluation after myocardial infarction and thrombolysis. Circulation 1997; 96: 2.932-2.937.
246. Sciagrà R, Bisi G, Santoro GM, Agnolucci M, Zoccarato O, Fazzini PF. Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardial with data-based quantitative technectium 99m-labeled sestamibi single photon emission computed tomography. J Nucl Cardiol 1996; 3: 221-230.
247. Bisi G, Sciagrà R, Santoro GM, Rossi V, Fazzini PF. Technetium 99m-setamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995; 36: 1.994-2.000.
248. Flotats A, Carrió I, Estorch M, Bernà L, Catafau AM, Marí C et al. Nitrate administration to enhance the detection of myocardial viability by technectium-99m tetrofosmin single photon emission tomography. Eur J Nucl Med 1997; 24: 767-773.
249. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M et al. Reversibility of cardiac wall-motion abormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
250. Tamaki N, Kawamoto M, Tadamura E, Magata Y, Yonekura Y, Nohara R et al. Pediction of reversible ischemia after revascularization: perfusion and metabolic studies with positron emission tomography. Circulation 1995; 91: 1.697-1.705.
251. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860-865.
252. Nienaber CA, Brunken RC, Sherman CT, Yeatmna LA, Gambhir SS, Krivokapich J et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991; 18: 966-978.
253. Eitzman D, Al-Aouar Z, Kanter HL, Dahl J, Kirsh M, Deeb JM et al. Clinical outcome of patients with advanced coronary artery disease after viability studies wilh positron emission tomography. J Am Coll Cardiol 1992; 20: 559-565.
254. DiCarli MF, Davidson M, Lille R, Khanna S, Mody FV, Brunken RC et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
255. Gould KL, Yoshida K, Hess MJ, Haynie M, Mullani N, Smalling RW. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med 1991; 32: 1-9.
256. Goldstein R. Kinetics of rubidium-82 after coronary occlusion and reperfusion. Assessment of patency and viability in openchest dogs. J Clin Invest 1985; 75: 1.131-1.137.
257. Gropler RJ, Geltman EM, Sampathkumaran K, Pérez JE, Moerlein SM, Sobel BE et al. Functional recovery after coronary re-vascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992; 20: 569-577.
258. Nicolai E, Cuocolo A, Pace L, Maurea S, Nappi A, Imbriaco M et al. Assessment of systolic wall thickening using technetium-99m methoxyisobutylisonitrile in patients with coronary artery disease: relation to thallium-201 scintigraphy with re-injection. Eur J Nucl Med 1995; 22: 1.017-1.022.
259. González P, Massardo T, Muñoz A, Jofré J, Ribera A, Jovanovich J et al. Is the addition of ECG gating to technetium-99m sestamibi SPET of value in the assessment of myocardial viability? An evaluation based on two-dimensional echocardiography following revascularization. Eur J Nucl Med 1996; 23: 1.315-1.322.
260. Jain A, Mahmarian JJ, Borges-Neto S, Jhonston DL, Cashion WR, Lewis JM et al. Clinical significance of perfusion defects by thallium-201 single photon emissiom tomography following oral dipyridamole early after coronary angioplasty. J Am Coll Cardiol 1988; 11: 970-976.
261. Hardoff R, Shaefer A, Gips S, Merdler A, Flugelman MY, Halon DA et al. Predicting late restenosis after coronary angioplasty by very early (12-14 hours) thallium-201 scintigraphy: implications with mechanisms of late coronary restenosis. J Am Coll Cardiol 1990; 15: 1.486-1.492.
262. Iskandrian AS, Lemick J, Ogilby JD, Untereker WJ, Cave V, Heo J. Early thallium-201 imaging after percutaneous transluminal coronary angioplasty: tomographic evaluation during adenosine-induced coronary hyperemia. J Nucl Med 1992; 23: 2.086-2.089.
263. O'Keefe JH Jr, Lapeyre AC, Holmes DR Jr, Gibbons RJ. Usefulness of early radionuclide angiography for identifyieng lowrisk patients for late restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1989; 61: 51-54.
264. Weiner DA, Ryan TJ, Parsons L, Fischer LI, Chaitman BR, Sheffield LT et al. Prevalence and prognostic significance of silent and symptomatic ischemia after coronary bypass surgery: a report from the Coronary Artery Surgery Study (CASS) randomized population. J Am Coll Cardiol 1991; 18: 343-348.
265. McConahay DR, Valdes M, McAllister BD, Crockett JE, Conn RD, Reed WA et al. Accuracy of treadmill testing in assessment of direct myocardial revascularization. Circulation 1977; 56: 548-552.
266. Ritchie JL, Narahara KA, Trobaugh GB, Williams DL, Hamilton GW. Thallium-201 myocardial imaging before and after coronary revascularization: assesssment of regional myocardial blood flow and graft patency. Circulation 1977; 56: 830-836.
267. Verani MS, Marcus ML, Spoto G, Rossi NP, Ehrardt JC, Razzak MA. Thallium-201 myocardial perfusion scintigrams in the evaluation of aorto-coronary saphenous bypass surgery. J Nucl Med 1978; 19: 765-772.
268. Bulkley BH, Hutchins GM, Bailey I, Strauss HW, Pin B. Thallium-201 imaging and gated blood pool scans in patients with ischemic and idiopathic congestive cardiomyopathy: a clinical and pathologic study. Circulation 1977; 55: 753-760.
269. Greenberg JM, Murphy JH, Okada RD, Pohost GM, Strauss HW, Boucher CA. Value and limitations of radionuclide angiography in determining the cause of reduced left ventricular ejection fraction: comparison of idiopathic dilated cardiomyopathy and coronary artery disease. Am J Cardiol 1985; 55: 541-544.
270. Palmeri ST, Bonow RO, Myers CE, Seipp C, Jenkins J, Green MV et al. Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography. Am J Cardiol 1986; 58: 607-613.
271. Schwartz RG, McKenzie WB, Alexander J, Sager P, D'Souza A, Manatunga A et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med 1987; 82: 1.109-1.118.
272. Steinherz LJ, Graham T, Hurwitz R, Sondheimer HM, Schwartz RG, Shaffer EM et al. Guidelines for cardiac monitoring of chil-dren during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 1992; 89: 942-949.
273. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900-905.
274. Bonow RO, Rosing DR, Bacharach SL, Green MV, Kent KM, Lipson LC et al. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 1981; 64: 787-796.
275. O'Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987; 76: 1.214-1.223.
276. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 796-804.
277. Aroney CN, Ruddy TD, Dighero H, Fifer MA, Boucher CA, Palacios IF. Differentiation of restrictive cardiomyopathy from pericardial constriction: assessment of diastolic function by radionuclide angiography. J Am Coll Cardiol 1989; 13: 1.007-1.014.
278. O'Connell JB, Henkin RE, Robinson JA, Subramanian R, Scanlon PJ, Gunnar R. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation 1984; 70: 58-62.
279. Dec GW, Palacios I, Yasuda T, Fallon JT, Khaw BA, Strauss HW et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990; 16: 97-104.
280. Sorensen SG, O'Rourke RA, Chaudhuri TK. Noninvasive quantification of valvular regurgitation by gated equilibrium radionuclide angiography. Circulation 1980; 62: 1.089-1.092.
281. Gibbons RJ. Equilibrium radionuclide angiography. En: Marcus ML, Schebert HR, Skorton DJ, Wolf GL, editores. Cardiac imaging. A companion to Braunwald's heart disease. Filadelfia: WB Saunders Co., 1991; 1.027-1.046.
282. Massardo T, Gal RA, Grenier RP, Schmidt DH, Port SC. Left ventricular volume calculation using a count-based ratio method applied to multigated radionuclide angiography. J Nucl Med 1990; 31: 450-456.
283. Levy WC, Cerqueira MD, Matsuoka DT, Harp GD, Sheehan FH, Stratton JR. Four radionuclide methods for left ventricular volume determination: comparison of a manual and an automated technique. J Nucl Med 1992; 33: 763-770.
284. Borer JS, Bacharach SL, Green MV, Kent KM, Henry WL, Rosing DR et al. Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography. Am J Cardiol 1978; 42: 351-357.
285. Dehmer GJ, Firth BG, Hillis LD, Corbett JR, Lewis SE, Parkey RW et al. Alterations in left ventricular volumes and ejection fraction at rest and during exercise in patients with aortic regurgitation. Am J Cardiol 1981; 48: 17-27.
286. Boucher CA, Kanarek DJ, Okada RD, Hutter AM Jr, Strauss HW, Pohost GM. Exercise testing in aortic regurgitation: comparison of radionuclide left ventricular ejection fraction with exercise performance at the anaerobic threshold and peak exercise. Am J Cardiol 1983; 52: 801-808.
287. Bonow RO, Rosing DR, Kent DM, Epstein SE. Timing of operation for chronic aortic regurgitation. Am J Cardiol 1982; 50: 325-336.
288. Bonow RO, Picone AL, McIntosh CL, Jones M, Rosing DR, Maron BJ et al. Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function. Circulation 1985; 72: 1.244-1.256.
289. Bonow RO, Rosing DR, Maron BJ, McIntosh CL, Jones M, Bacharach SL et al. Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation 1984; 70: 570-579.
290. Bonow RO. Timing of operation for chronic aortic regurgitation: influence of left ventricular function on clinical management. Herz 1984; 9: 319-332.
291. Bonow RO, Rosing DR, McIntosh CL, Jones M, Maron BJ, Lan KK et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation 1983; 68: 509-517.
292. Parker JA, Treves S. Radionuclide detection, localization, and quantification of intracardiac shunts between the great arteries. Prog Cardiovasc Dis 1977; 20: 121-150.
293. Galve E. Congenital heart disease. En: Candell Riera J, Ortega Alcalde D, editores. Nuclear cardiology in everyday practice. Dordrecht: Kluwer Academic Publishers, 1994; 282-294.
294. Evangelista A, Aguadé S, Candell Riera J, Ángel J, Galve E, García del Castillo H et al. Cuantificación del cortocircuito de la comunicación interauricular mediante oximetría, isótopos y ecocardiografía Doppler. Existe un método de referencia? Rev Esp Cardiol 1998; 51 (Supl 1): 2-9.
295. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P et al. Abnormal left ventricular filling; an early finding in mild to moderate systemic hypertension. Am J Cardiol 1984; 53: 120-126.
296. Cuocolo A, Sax FL, Brush JE, Maron BJ, Bacharach SL, Bonow RO. Left
297. Wasserman AG, Katz RJ, Varghese PJ, Leiboff RH, Bren GG, Schlesselman S et al. Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain. N Engl J Med 1984; 311: 1.276-1.280.
298. Christian TF, Zinmeister AR, Miller TD, Clements IP, Gibbons RJ. Left ventricular systolic response to exercise in patients with systemic hypertension without left ventricular hypertrophy. Am J Cardiol 1990; 65: 1.204-1.208.
299. Candell Riera J, Castell Conesa J. Exploraciones radioisotópicas en la cardiopatía hipertensiva. En: Iriarte Ezkurdia MM, editor. Cardiopatía hipertensiva. Madrid: Harcourt Brace 1997; 153-168.
300. Lee KJ, Wałis JW, Miller TR, Boman RM. The clinical utility of radionuclide ventriculography in cardiac transplantation. J Nucl Med 1990; 31: 1.933-1.939.
301. Follansbee WP, Kiernan JN, Curtiss EI, Zerbe TR, Mock C, Kormos RL. Changes in left ventricular systolic function that accompany rejection of the transplanted heart: a serial radionuclide assessment of fifty-three consecutive cases. Am Heart J 1991; 121: 548-556.
302. Addonizio LJ. Detection of cardiac allograft rejection using radionuclide techniques. Prog Cardiovasc Dis 1990; 33: 73-83.
303. Frist W, Yasuda T, Segall G, Khaw BA, Strauss HW, Gold H et al. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. Circulation 1987; 76(Supl 5): 81-85.
304. Carrió I, Bernà L, Ballester M, Estorch M, Obrador D, Cladellas M et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988; 29: 1.893-1.900.
305. Ballester M, Obrador D, Carrió I, Augé JM, Moya C, PonsLladó G et al. Indium-111 monoclonal antimyosin antibody studies after the first year of heart transplantation: identification of risk groups for developing rejection during long-term follow-up and clinical implications. Circulation 1990; 82: 2.100-2.108.
306. McKillop JH, Goris ML. Thallium-201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol 1981; 32: 447-449.
307. Smart FW, Ballantyne CM, Cocanougher B, Farmer JA, Sekela ME, Noon GP et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol 1991; 67: 243-247.
308. Rodney RA, Johnson LL, Blood DK, Barr ML. Myocardial perfusion scintigraphy in heart trasplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium-99m in sestamibi. J Heart Lung Transplant 1994; 13: 1.730-1.780.